Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig R Lee

Showing results (111-120 of 122) with videos related to

Pageof 13
Sort By:
Journal of the American Heart Association|June 14, 2024
<i>CYP2C19</i> Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary InterventionKayla R Tunehag, Cameron D Thomas, Francesco Franchi, et al.
Clinical Pharmacology and Therapeutics|October 28, 2022
Evaluation of Potential Racial Disparities in CYP2C19-Guided P2Y<sub>12</sub> Inhibitor Prescribing After Percutaneous Coronary InterventionLarisa H Cavallari, Nita A Limdi, Amber L Beitelshees, et al.
Clinical and Translational Science|August 16, 2024
Precision Antiplatelet Therapy after Percutaneous Coronary Intervention (Precision PCI) Registry - Informing optimal antiplatelet strategiesLarisa H Cavallari, Craig R Lee, Francesco Franchi, et al.
Clinical Pharmacology and Therapeutics|April 16, 2022
Impact of the ABCD-GENE Score on Clopidogrel Clinical Effectiveness after PCI: A Multi-Site, Real-World InvestigationCameron D Thomas, Francesco Franchi, Ellen C Keeley, et al.
Journal of the American College of Cardiology|April 10, 2024
Effectiveness of Clopidogrel vs Alternative P2Y<sub>12</sub> Inhibitors Based on the ABCD-GENE ScoreCameron D Thomas, Francesco Franchi, Joseph S Rossi, et al.
Journal of the American Heart Association|February 14, 2022
<i>CYP2C19</i> Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical SettingsAmber L Beitelshees, Cameron D Thomas, Philip E Empey, et al.
Clinical Pharmacology and Therapeutics|September 8, 2020
Impact of the CYP2C19*17 Allele on Outcomes in Patients Receiving Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary InterventionCraig R Lee, Cameron D Thomas, Amber L Beitelshees, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2013
Epoxyeicosanoids promote organ and tissue regenerationDipak Panigrahy, Brian T Kalish, Sui Huang, et al.
Clinical Pharmacology and Therapeutics|December 28, 2017
Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype-Guided Antiplatelet TherapyPhilip E Empey, James M Stevenson, Sony Tuteja, et al.
The Journal of Clinical Investigation|December 21, 2011
Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in miceDipak Panigrahy, Matthew L Edin, Craig R Lee, et al.
Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
Journal of the American Heart Association|June 14, 2024
<i>CYP2C19</i> Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary InterventionKayla R Tunehag, Cameron D Thomas, Francesco Franchi, et al.
Clinical Pharmacology and Therapeutics|October 28, 2022
Evaluation of Potential Racial Disparities in CYP2C19-Guided P2Y<sub>12</sub> Inhibitor Prescribing After Percutaneous Coronary InterventionLarisa H Cavallari, Nita A Limdi, Amber L Beitelshees, et al.
Clinical and Translational Science|August 16, 2024
Precision Antiplatelet Therapy after Percutaneous Coronary Intervention (Precision PCI) Registry - Informing optimal antiplatelet strategiesLarisa H Cavallari, Craig R Lee, Francesco Franchi, et al.
Clinical Pharmacology and Therapeutics|April 16, 2022
Impact of the ABCD-GENE Score on Clopidogrel Clinical Effectiveness after PCI: A Multi-Site, Real-World InvestigationCameron D Thomas, Francesco Franchi, Ellen C Keeley, et al.
Journal of the American College of Cardiology|April 10, 2024
Effectiveness of Clopidogrel vs Alternative P2Y<sub>12</sub> Inhibitors Based on the ABCD-GENE ScoreCameron D Thomas, Francesco Franchi, Joseph S Rossi, et al.
Journal of the American Heart Association|February 14, 2022
<i>CYP2C19</i> Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical SettingsAmber L Beitelshees, Cameron D Thomas, Philip E Empey, et al.
Clinical Pharmacology and Therapeutics|September 8, 2020
Impact of the CYP2C19*17 Allele on Outcomes in Patients Receiving Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary InterventionCraig R Lee, Cameron D Thomas, Amber L Beitelshees, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2013
Epoxyeicosanoids promote organ and tissue regenerationDipak Panigrahy, Brian T Kalish, Sui Huang, et al.
Clinical Pharmacology and Therapeutics|December 28, 2017
Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype-Guided Antiplatelet TherapyPhilip E Empey, James M Stevenson, Sony Tuteja, et al.
The Journal of Clinical Investigation|December 21, 2011
Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in miceDipak Panigrahy, Matthew L Edin, Craig R Lee, et al.
Pageof 13